Anticorps Monoclonal anti-SPARC

SPARC Monoclonal Antibody for IF/ICC

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, rat

Applications

IF/ICC

Conjugaison

CoraLite® Plus 488 Fluorescent Dye

CloneNo.

1A2C1

N° de cat : CL488-66426

Synonymes

Basement membrane protein 40, BM 40, ON, Osteonectin, SPARC



Applications testées

Résultats positifs en IF/ICCcellules C6,

Dilution recommandée

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

CL488-66426 cible SPARC dans les applications de IF/ICC et montre une réactivité avec des échantillons Humain, rat

Réactivité Humain, rat
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène SPARC Protéine recombinante Ag7390
Nom complet secreted protein, acidic, cysteine-rich (osteonectin)
Masse moléculaire calculée 35 kDa
Poids moléculaire observé 38 kDa, 52 kDa
Numéro d’acquisition GenBankBC004974
Symbole du gène SPARC
Identification du gène (NCBI) 6678
Conjugaison CoraLite® Plus 488 Fluorescent Dye
Excitation/Emission maxima wavelengths493 nm / 522 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA
Conditions de stockageStocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

SPARC, also known as ON (Osteonectin) or BM-40 (Basement-membrane protein 40), is an extracellular glycoprotein with the calculated molecular mass of 35 kDa and the apparent molecular mass of 40-43 kDa and 50 kDa (PMID: 7495300, 12365801). SPARC belongs to a group of matricellular proteins defined as secreted components that do not contribute directly to the formation of structural elements but serve to modulate cell-matrix interactions and cellular functions (PMID: 7542656; 12231357). SPARC is expressed at high levels in bone tissue, is distributed widely in many other tissues and cell types, and is associated generally with tissues undergoing morphogenesis, remodeling and wound repair (PMID: 10567433). It elicits changes in cell shape, inhibits cell-cycle progression, and influences the synthesis of extracellular matrix (PMID: 12721366). Altered expression of SPARC has been reported in a variety of cancers, which include breast, ovarian, colorectal, and pancreatic cancer as well as melanoma and glioblastomas (PMID: 18849185).

Protocole

Product Specific Protocols
IF protocol for CL Plus 488 SPARC antibody CL488-66426Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}